Position in ARGX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$97,376,646
-$14,494,932 QoQ
Shares Held
133,347
+0.2% QoQ
Ownership
0.214%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 24.25026434790434.ToString("F0")%
Shared 0.ToString("F0")%
None 75.74973565209567.ToString("F0")%
Common Shares in ARGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026LAZARD ASSET MANAGEMENT LLC holds $361,300,548 across 55 Biotechnology names. ARGX ranks #1 (27.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
This page
|
133,347 | $97,376,646 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
213,131 | $95,171,516 | |
| 3 | INCY |
Incyte Corp
|
219,881 | $20,695,199 | |
| 4 | ONC |
BeOne Medicines Ltd.
|
62,917 | $18,684,461 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
325,851 | $18,407,322 | |
| 6 | EXEL |
Exelixis, Inc.
|
372,600 | $15,980,814 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
17,004 | $13,137,970 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
42,723 | $8,076,783 |
All Filings in ARGX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $97,376,646 | 133,347 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $111,871,578 | 133,030 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $101,190,281 | 137,196 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $70,273,934 | 127,488 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $41,578,514 | 70,250 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $43,441,755 | 70,637 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $3,227,001 | 5,953 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $171,155 | 398 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $370,883 | 942 | Shares | Sole | 2024-07-09 | |
| 2023-12-31 | $1,269,114 | 3,336 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,207,418 | 4,490 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $70,151 | 180 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $67,064 | 180 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $581,882 | 1,536 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $542,284 | 1,536 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $73,502 | 194 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $61,170 | 194 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $67,936 | 194 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $114,458 | 379 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $114,105 | 379 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $104,372 | 379 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $109,989 | 374 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $98,182 | 374 | Shares | Sole | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||